workers, and other direct care providers with demonstrated Self-reported effectiveness to competently experience of engage PLWH HIV-related stigma by consumers in surveys Objective 2.4: By 2021, reduce HIV related mortality among PLWH by 10% Timeframe Activity Target Responsible Data Population Parties Indicators Ongoing Continue to administer access to Income eligible OHA Percent of health insurance premium and PLWH income-eligible medication co-payment assistance MA HIV Drug PLWH enrolled through the HIV Drug Assistance Assistance in HDAP Program to all income-eligible Program persons with HIV infection Ongoing Implement acuity-based medical PLWH OHA Number of case management (MCM) services clients enrolled in all regions of the state to ensure OHA-funded in state and access to health systems navigation, HPDP providers HRSA funded clinic- and community-based MCM services interventions to promote engagement and retention in care, Rates of linkage and adherence support to maximize and rates of viral suppression engagement in care among PLWH accessing MCM services Rates of viral suppression among PLWH accessing MCM services Through 2021 Offer enhanced engagement and Medical providers OHA Number of retention in care interventions to submitting HIV corrective HIV+ PWID and persons co-infected case report forms action plans with HIV and HCV that have higher developed and rates of mortality compared to completed other HIV+ populations Objective 2.5: By 2021, 90% of individuals co-infected with HIV and HCV will be linked to treatment Timeframe Activity Target Responsible Data Indicators Population Parties Ongoing Build capacity at syringe service Individuals OHA Percentage of programs to provide with HIV SSP participants comprehensive health promotion and HCV OHA-funded that are services for PWID, including syringe service provided routine testing for HIV/HCV and programs HIV/HCV testing
workers, and other direct care providers with demonstrated effectiveness to competently engage PLWH Self-reported experience of HIV-related stigma by consumers in surveys Objective 2.4: By 2021, reduce HIV related mortality among PLWH by 10% Timeframe Activity Target Population Responsible Parties Data Indicators Ongoing Continue to administer access to health insurance premium and medication co-payment assistance through the HIV Drug Assistance Program to all income-eligible persons with HIV infection Income eligible PLWH OHA MA HIV Drug Assistance Program Percent of income-eligible PLWH enrolled in HDAP Ongoing Implement acuity-based medical case management (MCM) services in all regions of the state to ensure access to health systems navigation, clinic- and community-based interventions to promote engagement and retention in care, and adherence support to maximize rates of viral suppression PLWH OHA OHA-funded HPDP providers Number of clients enrolled in state and HRSA funded MCM services Rates of linkage and engagement in care among PLWH accessing MCM services Rates of viral suppression among PLWH accessing MCM services Through 2021 Offer enhanced engagement and retention in care interventions to HIV+ PWID and persons co-infected with HIV and HCV that have higher rates of mortality compared to other HIV+ populations Medical providers submitting HIV case report forms OHA Number of corrective action plans developed and completed Objective 2.5: By 2021, 90% of individuals co-infected with HIV and HCV will be linked to treatment Timeframe Activity Target Population Responsible Parties Data Indicators Ongoing Build capacity at syringe service programs to provide comprehensive health promotion services for PWID, including routine testing for HIV/HCV and Individuals with HIV and HCV OHA OHA-funded syringe service programs Percentage of SSP participants that are provided HIV/HCV testing